Karen Kelly
American Cancer Society(US)Thomas Jefferson University(US)Colorado Women's College(US)Naval Health Research Center(US)Sidney Kimmel Cancer Center(US)International Association for the Study of Lung Cancer(US)UC Davis Comprehensive Cancer CenterUniversity of California, Davis(US)Stanford University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer(2003)2,533 cited
- → Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial(2001)1,127 cited
- → Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade(2018)823 cited
- → Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study(2017)581 cited
- → Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023(2008)569 cited
- →